NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Edwards’ Ecliptis Wins FDA Clearance, Challenges AtriCure in Surgical LAA Market

Edwards got FDA OK for heart clip; it enters a market led by AtriCure, adding competition but not changing the outlook much.

Edwards’ Ecliptis Wins FDA Clearance, Challenges AtriCure in Surgical LAA Market
Credit: Edwards Lifesciences
Already have an account? Sign in.
06/29/2026 · 3:42 PM
ATRC
/ Read more

Feed↓

FDA Clears Gain Therapeutics’ GT-02287 for Phase 2 Parkinson’s Trials
06/29/2026 · 5:06 PM

FDA Clears Gain Therapeutics’ GT-02287 for Phase 2 Parkinson’s Trials

Phase 2 trials in early Parkinson’s to start Q3 2026 in U.S. & Europe after strong Phase 1 biomarker and safety data.

/ Subscriber only
AeroVironment Soars on Record Q4 Results, Beats Expectations by Wide Margin
06/29/2026 · 4:33 PM

AeroVironment Soars on Record Q4 Results, Beats Expectations by Wide Margin

AeroVironment reported record Q4 FY2026 revenue of $641.6M (+133% YoY) and non-GAAP EPS of $1.84, beating expectations.

/ Subscriber only
Jana Partners Raises Stake in Alkami to Over 10% and Intensifies Sale Push
06/29/2026 · 4:06 PM

Jana Partners Raises Stake in Alkami to Over 10% and Intensifies Sale Push

The activist investor is pushing for leadership changes and a broad sale process.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe